Blood
Издатель: Elsevier · ISSN 0006-4971 · 75 статей
- Eltrombopag plus cyclosporine for moderate aplastic anemia: a placebo-controlled, double-blind phase 3 trial
- Fixed-duration epcoritamab plus R-CHOP for newly diagnosed LBCL with an IPI score of 3 to 5: results from the EPCORE NHL-2 trial
- Prospective comparison of 28 vs 14 days of venetoclax induction with azacitidine in older adults with untreated AML: OPTI-AML trial
- Measurable residual disease–dependent unfavorable outcomes in pediatric PAX5-rearranged B-acute lymphoblastic leukemia
- NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib
- The hepatic FGFR-ERK-HRG axis regulates heparin-induced thrombocytopenia with thrombosis
- Factor V is an anticoagulant of the extrinsic pathway of coagulation and a modifier of thrombin generation in hemophilia A
- Not everything that looks like a gametocyte is malaria
- Eltrombopag for moderate aplastic anemia
- Endothelial IDO1 Drives BBB Disruption in CAR-T-Associated Neurotoxicity Through KYNU-AA-Wnt/β-catenin Pathway
- Central nervous system graft-versus-host disease pathophysiology: mechanistic pathways and therapeutic targets
- Immunologic & Plasma-Dependent Mechanisms of Chronic Hemolysis and Hyperhemolysis in Sickle Cell Disease
- Thrombin-mediated AutoRegulation of FVIII-mimetic antibodies enabling dynamic control of the hemostatic response
- Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific Antibody
- Regenerative Stress Contributes to Higher Clonal Hematopoiesis with Myelodysplastic Features in Sickle Cell Disease Mice
- Microbiota-derived short-chain fatty acids control cGVHD development by regulating antibody production
- Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial
- Initial fixed low-versus moderate-dose hydroxyurea assignment in the long-term follow-up of the SPRINT cohort
- Molecular Underpinnings and Prevalence of Donor Cell–Derived Hematologic Neoplasms among Spanish Transplantation Centers
- Evolving Paradigms in Hematology: Splicing Factor Mutations in Myeloid Malignancies
- Peginterferon alfa-2a, bictegravir–emtricitabine–tenofovir alafenamide, and venetoclax in adult T-cell leukemia/lymphoma
- Multi-omics reveals evolution from CD7-negative T cell dysregulation to EBV-positive LPD after CD7 CAR-T therapy
- Low Incidence of Cryptic Genetic Marrow Failure in Pediatric Severe Aplastic Anemia Following Negative Clinical Workup
- Identifying novel genomic alterations in relapsed childhood B-ALL: a report from the Children’s Oncology Group
- Less is more: expanding human HSCs via a novel mimetic niche
- Prime advantage: making T cells drug resistant
- MRD is a journey, not a snapshot
- Epigenetically activating T cells to attack AML
- A kindlin splice for stressful times
- Chasing the Aurora: naturally occurring prothrombotic FVIII